These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2379411)

  • 1. Bretylium intoxication resembling clinical brain death--or did it?
    Dobb G
    Crit Care Med; 1990 Aug; 18(8):901-2. PubMed ID: 2379411
    [No Abstract]   [Full Text] [Related]  

  • 2. Bretylium intoxication resembling clinical brain death.
    Moore JK; Moore AP
    Crit Care Med; 1990 Mar; 18(3):347. PubMed ID: 2302967
    [No Abstract]   [Full Text] [Related]  

  • 3. Bretylium intoxication resembling clinical brain death.
    Thompson AE; Sussmane JB
    Crit Care Med; 1989 Feb; 17(2):194-5. PubMed ID: 2914454
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
    Holland K; Patterson E; Lucchesi BR
    Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the positive inotropic responses to bretylium and guanethidine.
    BHAGAT B; SHIDEMAN FE
    Br J Pharmacol Chemother; 1963 Feb; 20(1):56-62. PubMed ID: 13967966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bretylium opens mucosal amiloride-sensitive sodium channels.
    Ilani A; Lichtstein D; Bacaner MB
    Biochim Biophys Acta; 1982 Dec; 693(2):503-6. PubMed ID: 6297561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bretylium tosylate: a review.
    Bryan CK; Darby MH
    Am J Hosp Pharm; 1979 Sep; 36(9):1189-92. PubMed ID: 386786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular bretylium blocks Na+ and K+ currents in heart cells.
    Bkaily G; Payet MD; Benabderrazik M; Sauvé R; Renaud JF; Bacaner M; Sperelakis N
    Eur J Pharmacol; 1988 Jul; 151(3):389-97. PubMed ID: 2850920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
    Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
    Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial.
    Haynes RE; Chinn TL; Copass MK; Cobb LA
    Am J Cardiol; 1981 Aug; 48(2):353-6. PubMed ID: 7023224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bretylium on neuromuscular transmission.
    Welch GW; Waud BE
    Anesth Analg; 1982 May; 61(5):442-4. PubMed ID: 6278989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
    Puddu PE; Jouve R; Saadjian A; Torresani J
    J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of acetylcholinesterase with a bretylium tosylate photoaffinity probe.
    Branchini BR; Lajiness EJ
    Biochim Biophys Acta; 1986 Oct; 884(1):135-41. PubMed ID: 3768408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bretylium: a prototype for future development of antidysrhythmic agents.
    Patterson E; Lucchesi BR
    Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235
    [No Abstract]   [Full Text] [Related]  

  • 15. THE SYMPATHETIC POSTGANGLIONIC FIBRE AND THE BLOCK BY BRETYLIUM; THE BLOCK PREVENTED BY HEXAMETHONIUM AND IMITATED BY MECAMYLAMINE.
    BURN JH; GIBBONS WR
    Br J Pharmacol Chemother; 1964 Jun; 22(3):549-57. PubMed ID: 14211685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac arrhythmias produced by bretylium in cats anesthetized with halothane.
    Condouris GA; Ortiz J; Lyness W
    Eur J Pharmacol; 1979 Apr; 55(1):93-7. PubMed ID: 35358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical suppression of refractory ventricular tachycardia with oral bretylium not predicted by electrophysiologic drug testing.
    Grubb BP; Luck JC; Bacaner M
    Chest; 1988 Aug; 94(2):430-2. PubMed ID: 3396427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle.
    Breznock EM; Kagan K; Hibser NK
    Am J Vet Res; 1977 Jan; 38(1):89-94. PubMed ID: 835872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; Pickron J; Goldman AM
    Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic testing of bretylium tosylate in sustained ventricular tachycardia.
    Bauernfeind RA; Hoff JV; Swiryn S; Palileo E; Strasberg B; Scagliotti D; Rosen KM
    Am Heart J; 1983 Jun; 105(6):973-80. PubMed ID: 6858846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.